AK
Therapeutic Areas
Allecra Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cefepime/Enmetazobactam | Complicated Urinary Tract Infections (cUTI) | Phase 3 |
Leadership Team at Allecra Therapeutics
PV
Patrick Velicitat, MD
Chief Medical Officer
OL
Omar Lahlou, PhD
Head, Regulatory Affairs
AB
Adam Belley, PhD
Head, R&D